Search

everythinglearnresearchcommunity

for

Search:↓

Co-trimoxazole successfully treated a girl with multiple autoimmune symptoms.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

People with alopecia areata often have thyroid autoimmunity.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Stress may trigger hair loss by affecting immune protection in hair follicles.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Hair follicles are complex, dynamic mini-organs that help us understand cell growth, death, migration, and differentiation, as well as tissue regeneration and tumor biology.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

A systematic approach is crucial for managing hair loss in women.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Immune cells affect hair growth and could lead to new hair loss treatments.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.